Objective The association between nutritional status and prognosis of idiopathic pulmonary
fibrosis (IPF) remains unclear. This systematic review and meta-analysis aimed to explore …

In therapeutic studies in idiopathic pulmonary fibrosis (IPF), the low prevalence of significant
change in pulmonary functional tests (PFTs) has been a major constraint. The prognostic …

Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive fibrotic disease limited to the
lung, with high variability in the course of disease from one patient to another. Patients with …

Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic disorder and ultimately fatal
disease. Acute exacerbation of IPF (AE-IPF) is defined as a rapid deterioration with new …

Background A better capacity to identify patients with idiopathic pulmonary fibrosis (IPF) at
risk of acute exacerbation (AEIPF) might improve outcomes and reduce healthcare costs …

Idiopathic pulmonary fibrosis (IPF) is a relentlessly progressive disease by definition (1).
Based on clinical trial endpoints, the FVC was identified as a marker of disease progression …

Objectives The peak expiratory flow rate (PEFR) is known to decrease in patients with
sarcopenia. However, little is known about the clinical impact of the PEFR in idiopathic …

Introduction Acute exacerbation (AE) is a severe complication of idiopathic pulmonary
fibrosis (IPF), which shares some common pathological features with acute respiratory …

Background Recent years, idiopathic pulmonary fibrosis (IPF) is thought to be a disease of
alveoli as well as small airways. This study aimed to demonstrate the clinical feature …

Background Idiopathic pulmonary fibrosis is a fibrotic disease of unknown aetiology and has
a poor prognosis. Some patients experience episodes of rapid deterioration known as acute …